Nova Mentis Life Science Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA66980V1067
CAD
0.10
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Nova Mentis Life Science Corp. stock-summary
stock-summary
Nova Mentis Life Science Corp.
Pharmaceuticals & Biotechnology
Nova Mentis Life Science Corp., formerly Liberty Leaf Holdings Ltd., is a Canada-based company focused on developing a portfolio of health and wellness businesses. The Company's portfolio of holdings includes Nova Mentis Biotech Corp (NovaMentis BioTech), Just Kush Enterprises and Pilz Bioscience Corp. NovaMentis BioTech is a research and development company focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes. Just Kush Enterprises operates a cannabis facility. Pilz Bioscience Corp is a biotechnology company developing medicinal psychedelics for neuroinflammatory conditions with a cognitive component and unmet therapeutic needs. It is initially focused on Autism Spectrum Disorder (ASD).
Company Coordinates stock-summary
Company Details
700-838 W Hastings Street , VANCOUVER BC : V6C 0A6
stock-summary
Tel: 1 778 8190244
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Rascan
President, Chief Executive Officer, Director
Mr. Steven Feldman
Independent Director
Mr. Doug Macdonell
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 2 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

-78.86%

stock-summary
Price to Book

1.72